Delisting risk
Callan JMB (CJMB)
Emergency-readiness logistics and temperature-controlled packaging for medical supply chains.
$2.06
Pre-market−0.12 (−5.50%)
At close$2.18(+2.35%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Cost of revenue | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Gross profit | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
| 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
| 1 | 2 | 1 | 1 | 3 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | −1 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 0 | 2 | 0 | 0 | 3 | 3 | 2 | 2 | 0 | 0 | 0 | 0 |
| Other expenses | 0 | −1 | 0 | 0 | −2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | 1 | −1 | 0 | 0 | −1 | −1 | −1 | −1 | −2 | −2 | −2 | −1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | −1 | −2 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 0 |
| Income before tax | 1 | −1 | 0 | 0 | −1 | −1 | −1 | −1 | −3 | −3 | −3 | −1 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | 1 | −1 | 0 | 0 | −1 | −1 | −1 | −1 | −3 | −3 | −3 | −1 |
| Net income | 1 | −1 | 0 | 0 | −1 | −1 | −1 | −1 | −3 | −3 | −3 | −1 |
| EPS, basic | $0.13 | −$0.15 | −$0.03 | −$0.04 | −$0.27 | −$0.43 | −$0.32 | −$0.31 | −$0.61 | −$0.58 | −$0.59 | −$0.22 |
| EPS, diluted | $0.13 | −$0.15 | −$0.03 | −$0.02 | −$0.13 | −$0.22 | −$0.21 | −$0.31 | −$0.61 | −$0.58 | −$0.59 | −$0.22 |
| Weighted average shares, basic | 5 | 5 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 6 |
| Weighted average shares, diluted | 5 | 5 | 3 | 8 | 6 | 6 | 6 | 4 | 4 | 4 | 5 | 6 |
| EBITDA | 1 | −1 | 0 | 0 | −1 | −1 | −1 | −1 | −3 | −3 | −3 | −1 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 1 | −1 | 0 | 0 | −1 | −1 | −1 | −1 | −3 | −3 | −3 | −1 |